99 filings
Page 3 of 5
EFFECT
uwgp75wj42zqg qw8g
19 Nov 21
Notice of effectiveness
12:15am
8-K/A
cal7vjp
18 Nov 21
Departure of Directors or Certain Officers
5:03pm
CORRESP
ult5c1 18lakjktc
16 Nov 21
Correspondence with SEC
12:00am
UPLOAD
dwtg39iy fz7o7
15 Nov 21
Letter from SEC
12:00am
S-3
7bna8v7
12 Nov 21
Shelf registration
12:00am
8-K
76nww2vhuri65w8f5
4 Nov 21
Departure of Directors or Certain Officers
4:58pm
8-K
9ntp yy7e
26 Oct 21
SQZ Biotechnologies Announces Independent DSMB Recommendation to Advance Lead Cell Therapy Candidate into Combination
6:54am
8-K
342c f29fwg9yfk88cyo
13 Sep 21
SQZ Biotechnologies Announces First Autoimmune Disease Indication
6:53am
8-K
e9jo9z622qa
2 Sep 21
Departure of Directors or Certain Officers
5:00pm
8-K/A
ntwfg62nszkmpdzuy3
29 Jul 21
Departure of Directors or Certain Officers
5:00pm
8-K
0s5oeluw 97
1 Jul 21
SQZ Biotechnologies Strengthens Board with Global Commercial and Clinical Development Experience
5:07pm
8-K
kh8q7k7
17 Jun 21
Submission of Matters to a Vote of Security Holders
5:18pm
8-K
qbvkd k4t2qr0qq2q
4 Jun 21
Regulation FD Disclosure
8:09am
DEFA14A
6p1cx9ct5e55eucoaby
26 Apr 21
Additional proxy soliciting materials
5:10pm
DEF 14A
yxqihitg29 2i
26 Apr 21
Definitive proxy
5:00pm
10-K
7qa14jjp d56o
18 Mar 21
Annual report
6:31am
8-K
wwvg9a0ozjyecfii
25 Feb 21
Departure of Directors or Certain Officers
5:00pm